doi: 10.1021/jm500303u.
Epub 2014 Jul 8.
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells
Affiliations
- PMID: 24972008
- DOI: 10.1021/jm500303u
Item in Clipboard
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells
J Med Chem.
.
Abstract
We describe 1,3,4-oxadiazole-containing hydroxamates (2) and 2-aminoanilides (3) as histone deacetylase inhibitors. Among them, 2t, 2x, and 3i were the most potent and selective against HDAC1. In U937 leukemia cells, 2t was more potent than SAHA in inducing apoptosis, and 3i displayed cell differentiation with a potency similar to MS-275. In several acute myeloid leukemia (AML) cell lines, as well as in U937 cells in combination with doxorubicin, 3i showed higher antiproliferative effects than SAHA.
Similar articles
-
tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.ChemMedChem. 2013 May;8(5):800-11. doi: 10.1002/cmdc.201300005. Epub 2013 Mar 25. ChemMedChem. 2013. PMID: 23526814
-
Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.Eur J Med Chem. 2015;96:1-13. doi: 10.1016/j.ejmech.2015.04.002. Epub 2015 Apr 6. Eur J Med Chem. 2015. PMID: 25874326
-
Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.Bioorg Med Chem. 2016 Nov 1;24(21):5611-5617. doi: 10.1016/j.bmc.2016.09.022. Epub 2016 Sep 12. Bioorg Med Chem. 2016. PMID: 27665180
-
Inhibitors of histone deacetylase as antitumor agents: A critical review.Bioorg Chem. 2016 Aug;67:18-42. doi: 10.1016/j.bioorg.2016.05.005. Epub 2016 May 17. Bioorg Chem. 2016. PMID: 27239721 Review.
-
1,3,4-Oxadiazoles as Potential Pharmacophore for Cytotoxic Potentiality: A Comprehensive Review.Curr Top Med Chem. 2021;21(15):1377-1397. doi: 10.2174/1568026621666210612031144. Curr Top Med Chem. 2021. PMID: 34126902 Review.
Cited by
-
Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine) Derivatives as EGFR/CDK-2 Target Inhibitors.ACS Omega. 2023 Sep 11;8(38):35359-35369. doi: 10.1021/acsomega.3c05309. eCollection 2023 Sep 26. ACS Omega. 2023. PMID: 37779952 Free PMC article.
-
Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy.Biomedicines. 2023 Feb 21;11(3):654. doi: 10.3390/biomedicines11030654. Biomedicines. 2023. PMID: 36979633 Free PMC article. Review.
-
Crystal structure and Hirshfeld surface analysis of ethyl (3E)-5-(4-chloro-phen-yl)-3-{[(4-chloro-phen-yl)formamido]-imino}-7-methyl-2H,3H,5H-[1,3]thia-zolo[3,2-a]pyrimidine-6-carboxyl-ate.Acta Crystallogr E Crystallogr Commun. 2022 Jul 26;78(Pt 8):846-850. doi: 10.1107/S205698902200603X. eCollection 2022 Aug 1. Acta Crystallogr E Crystallogr Commun. 2022. PMID: 35974819 Free PMC article.
-
Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives.Pharmaceuticals (Basel). 2021 May 6;14(5):438. doi: 10.3390/ph14050438. Pharmaceuticals (Basel). 2021. PMID: 34066442 Free PMC article.
-
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application.Clin Epigenetics. 2021 Aug 27;13(1):166. doi: 10.1186/s13148-021-01154-x. Clin Epigenetics. 2021. PMID: 34452630 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous
